In Phase II data released this week, people taking a monthly dose of PF’3944 continued to lose more weight than those on a ...

None of the conventional wisdom applies when you're making a Super Bowl ad.

To counterbalance this, AI-driven predictive technology is helping clinicians to identify risk early enough for closer ...

The U.S. stock market sank after a mixed day of trading. The S&P 500 fell 0.8% Tuesday. The Dow Jones Industrial Average ...

Cardiologist shares how to identify 1st sign of heart attack, silent symptoms: 'Rarely feels like sharp, stabbing pain' Aamir ...

Planet Money went to the annual meeting of the American Economics Association, and we saw some fascinating papers presented ...

While you need $2.2 million to retire in Hawaii, you don’t have to be a millionaire to lead a comfortable life in retirement ...

Pfizer reported a quarterly loss Tuesday following a large write-down, denting shares as it confirmed 2026 financial targets with lower revenues. "Current financial guidance does not anticipate any ...

1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...

Often, the mindset divide is bigger. Across the day, speakers converged on one practical point patient safety outcomes increasingly depend on how well the ecosystem works as a coordinated whole, ...

HONG KONG – Asia shares were mixed on Wednesday following Wall Street losses weighed down by technology stocks, while gold and silver continued to regain ground after a recent sell-off.

Nearly three months after winning a contentious bid to buy obesity drugmaker Metsera Inc. for $10 billion, Pfizer Inc. reported its first statistically significant data of the acquired lead, ...